Dr. R K Choudhary

Dr. R. K. Choudhary is a highly experienced Oncologist with 22 years of dedicated practice, serving the Noida community. He is recognized for his comprehensive approach to cancer care, specializing in both Medical Oncology and Hemato-Oncology. Dr. Choudhary's extensive background and commitment to patient well-being have established him as a respected figure in the field. Dr. Choudhary's educational journey includes an MBBS, followed by an MD in Medicine. He further honed his expertise by completing a DNB in Medical Oncology. His foundational medical training was undertaken at Maulana Azad Medical College, a premier institution, and his postgraduate specialization in Oncology was pursued at Army Hospital (Research & Referral), another apex institute. With over two decades of experience, Dr. Choudhary possesses a broad range of clinical expertise in treating various cancers, including lung, breast, ovarian, stomach, and colon cancers, as well as hematological malignancies such as lymphoma, leukemia, and multiple myeloma. His areas of focus encompass advanced treatment modalities including infusional and oral chemotherapy, targeted therapy, neoadjuvant chemotherapy, immunotherapy, and bone marrow transplantation. Patients can expect a compassionate and thorough evaluation, with treatment plans tailored to their individual needs and the latest advancements in oncological care. Dr. Choudhary is affiliated with Metro Multispeciality Hospital, where he contributes his extensive knowledge and skills to patient care. He is an active participant in academic and research endeavors, regularly engaging in national and international conferences and continuing medical education programs. His professional memberships include prestigious organizations such as the National Academy of Medical Sciences (NAMS), the European Society for Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is also a founding member and Vice President of the Young Oncologists Group of India, demonstrating his commitment to the advancement of oncology.